The efficacy of treatment was respectively .% by per protocol(PP) and . % by intend to treat(ITT) in the Betahistine mesilate group and 9. % by PP and .7% by ITT in the control group.
详情正文
登录后查看完整内容
使用 DeepEvidence / 梅斯账号登录，新用户可在登录页面注册。
登录 / 注册登录成功后将返回当前页面，继续浏览。